In this second of two studies by Stanford researchers on low dose naltrexone’s effectiveness in Fibromyalgia (FM), LDN was found to significantly reduce pain and improve mood and quality of life. About 60% of study participants reported pain reductions of at...
Hemispherx released a statement on Monday indicating the FDA had denied their application of Ampligen to treat Chronic Fatigue Syndrome (ME/CFS) because of a lack of ‘substantial’ proof of efficacy and (rather ominously) because they did not have enough...
The plight of the chronic fatigue syndrome community was given a sympathetic and moving portrayal in a TV news story in Reno yesterday that featured Bob Miller and Dr. Janet Smith, another Ampligen recipient. The news organization contacted both the FDA and...
Bob Miller has been to the Vice President’s office, he’s had one and one meetings with the Director of the NIH, he’s canvassed politicians on the Hill – he’s thrown everything he can into the fight to get this disorder recognition –...
Some quick hits from the daylong celebration of the opening of Dr. Klimas Institue for Neuro-Immune Medicine at Nova Southeastern University. The full blog of the day will be posted on the Simmaron Rising page on the Simmaron Research Foundations website. Dean...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.